After finishing at $1.16 in the prior trading day, Adial Pharmaceuticals Inc (NASDAQ: ADIL) closed at $1.13, down -2.59%. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 1052870 shares were traded.
Ratios:
Our goal is to gain a better understanding of ADIL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 30, 2018, initiated with a Buy rating and assigned the stock a target price of $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 29 ’23 when Schuyler Kevin bought 700 shares for $2.74 per share. The transaction valued at 1,918 led to the insider holds 700 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADIL now has a Market Capitalization of 1.91M and an Enterprise Value of -205.86k.
Stock Price History:
Over the past 52 weeks, ADIL has reached a high of $14.00, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 1.4580, while the 200-Day Moving Average is calculated to be 2.8694.
Shares Statistics:
The stock has traded on average 3.99M shares per day over the past 3-months and 295.45k shares per day over the last 10 days, according to various share statistics. A total of 4.05M shares are outstanding, with a floating share count of 3.67M. Insiders hold about 9.50% of the company’s shares, while institutions hold 6.55% stake in the company. Shares short for ADIL as of Mar 15, 2024 were 105.63k with a Short Ratio of 0.03, compared to 173.32k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.35% and a Short% of Float of 6.81%.
Earnings Estimates
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.35 for the current quarter, with a high estimate of -$0.33 and a low estimate of -$0.37, while EPS last year was -$2.75. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.33 and low estimates of -$0.37.
Analysts are recommending an EPS of between -$1.36 and -$1.46 for the fiscal current year, implying an average EPS of -$1.41. EPS for the following year is -$7.04, with 2 analysts recommending between -$1.27 and -$12.82.
